Capricor Therapeutics | CAPR - Gross Profit On Sales


Capricor Therapeutics reported 11.13M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Bioline Rx USD 382K 39K Mar/2026
Capricor Therapeutics 11.13M 8.87M Dec/2024
Cipla INR 44.1B 5B Jun/2026
Cytokinetics USD 19.2M 1.44M Mar/2026
Geron USD 50.14M 3.44M Mar/2026
Grifols EUR 766.49M 39.74M Dec/2024
Immunic 0 0 Mar/2025
J&J USD 18.55B 1.31B Jun/2026
Plus Therapeutics 1.37M 30K Dec/2025
Prothena USD 51.08M 51.06M Mar/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026